On February 18, 2026, Supernus Pharmaceuticals, Inc. approved salary increases for key executives, including: Jack A. Khattar’s salary rising from $1,036,000 to $1,067,100, and Timothy C. Dec’s increasing from $504,900 to $525,100, among others, as part of an annual compensation review.